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Abstract
Background: There is substantial evidence that a virus homologous to mouse mammary tumor virus (MMTV) may
have a role in human breast cancer. The present study indicates that those who developed breast cancer
associated with an MMTV-like virus had this virus in their non-cancerous breast tissues years before the cancer
developed.
Methods: Polymerase chain reaction (PCR) techniques and sequencing were used to identify MMTV-like envelope
gene sequences (MMTV-like env sequences) in Australian benign breast biopsy specimens from women who several
years later developed breast cancer. Murine contamination was excluded by stringent laboratory procedures, and
the absence of intracisternal A particle sequences and mitochondrial cyclooxygenase sequences.
Results: MMTV-like env sequences (also called HMTV sequences to denote their source) were found in 9 of 25
breast cancer specimens (36%). Among 25 non-cancerous breast biopsies of these same patients taken 1 to
11 years earlier, six contained MMTV-like sequences (24%). Five of the six were among the nine virally-associated
breast cancers. In two pairs of specimens, benign and malignant, env sequences were 97% identical.
Conclusions: The identification of MMTV (MMTV-like) sequences in breast tissues prior to the development of
MMTV positive breast cancer fulfills a key criterion for a possible causal role for the MMTV-like virus in human breast
cancer.
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Background
Mouse mammary tumor viruses (MMTV) have a well-
documented causal role in mouse mammary tumors in
feral and experimental mice [1]. This role of MMTV
was first observed by John Bittner in 1936 [2]. These ob-
servations led to the search for a similar virus in human
breast cancer. Close morphologic and immunologic
similarity were repeatedly shown. More recently, near
identity of molecular structure to MMTV (90-98%) has
been identified in human breast cancers [3]. The
MMTV-like virus in humans is also called human mam-
mary tumor virus (HMTV) [4].
The evidence of a role for an MMTV-like virus in hu-
man breast cancer is substantial but incomplete. An es-
sential criterion to establish a causal role of an infectious
agent in any disease, including cancer, is evidence of
prior infection by the suspect agent [5]. This criterion
had not been investigated with respect to MMTV-like
virus. MMTV-like env sequences have rarely been iden-
tified in benign breast tissues [3, 6, 7], nor in the benign
breast tissue of individuals with breast cancer containing
MMTV-like sequences [8]. For this reason we sought to
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identify MMTV-like env sequences in benign breast bi-
opsy tissues from women who some years later devel-
oped MMTV-like positive breast cancer.
The evidence suggestive of a role for an MMTV–like
virus in human breast cancer is as follows: (i) a meta-
analysis of 22 studies concluded that the identification of
MMTV–like gene sequences in breast cancer tissues,
was associated with a 15 fold increase in breast cancer
[9], (ii) MMTV-like env gene sequences were identified
in 38% of US human breast tumors but were extremely
uncommon in healthy breast tissues [3, 6], (iii) the near
complete proviral structure of MMTV-like virus that
was 95-98% homologous to MMTV has been identified
in human breast tumors [4, 10], (iv) MMTV viral pro-
teins have been identified in human breast cancer [11],
(v) Wnt-1 oncogene expression is significantly higher in
MMTV-like positive compared to MMTV-like negative
breast cancer specimens, which parallels high Wnt-1 ex-
pression in MMTV positive mouse mammary tumors
[12, 13], (vi) MMTV can infect human cells and ran-
domly integrate its genomic information [14, 15], and
produce virus particles [16] (vii) there is increased preva-
lence of MMTV-like viral sequences in healthy breast
tissues (nil), healthy tissue adjacent to breast cancer
(19%), breast hyperplasia (27%), ductal carcinoma in situ
(82%) [17], (viii) the age standardized rates for breast
cancers in five countries of Asia are less frequent
(29–43 per 100,000) than in seven countries of Europe,
the Americas, and Australia (47–92) [18]. These findings
correlate with different burdens of MMTV-like infection
in human breast cancers, 0-20% in Asia vs. 27-60%, in the
seven countries which are associated with different
prevalence of MMTV in the indigenous mouse spe-
cies [18, 19]. (ix) MMTV–like sequences have been
identified in milk from healthy lactating women and
three fold positivity in milk from women at high risk
for breast cancer [20, 21], (x) MMTV-like sequences
have been identified in the saliva of 27% of healthy
children, 11% of healthy adults and 57% of adults
with breast cancer, which is suggestive of a human to
human viral transmission [22] and (xi) MMTV-like
viral sequences have been identified in breast cancers
which developed in a father, mother and daughter of
the same family which is suggestive of an infectious
condition [23]. Overall this evidence is consistent with
MMTV having similar influences in both human breast
cancer and mouse mammary tumors.
If an MMTV-like virus infects human breasts,
MMTV-like antibodies should be present in the sera of
infected individuals since mice infected with MMTV de-
velop high titers of MMTV specific antibodies. Indeed,
MMTV antibodies in human breast cancer have been
described [24, 25]. Antibodies were not identified in one
recent study, however [26].
Methods
Ethics
This project was formally considered and approved by
the Human Research Ethics Committees of the several
participating institutions.
Twenty five patients were identified for whom both
benign breast and subsequent breast cancer specimens
were available from the archives of an Australian path-
ology service (Douglass Hanly Moir – Pathology). All
the specimens were formalin fixed and paraffin
mounted. Seventeen of these sets of specimens were
analysed by polymerase chain reaction (PCR) techniques
at the Icahn School of Medicine at Mount Sinai
(ISMMS) (New York). Eight additional specimen pairs
were analysed by the same PCR techniques but with the
cancer tissues microdissected from the specimens at the
University of Pisa (UP) (Italy). Eight of the sets of speci-
mens were analysed in both Centers.
Detection of MMTV-like env sequences
The DNA extraction and detection of MMTV-like env
sequences were performed by PCR techniques as de-
scribed by Wang et al. [3]. The primer sequences used
in these PCR analyses include part of the MMTV env
gene, which differs from human endogenous retrovirus
10 (HERV-K10). The same PCR techniques were used in
both the ISMMS and UP laboratories with the exception
of microdissection of the tumor tissues, that were ana-
lysed in the UP laboratory by fluorescence nested PCR.
Materials from all patients were not available due to the
exhaustion of the blocks. The outcomes from each of
the two laboratories are shown in Table 1.
Contamination is a well-known problem with PCR
analyses. Therefore, all reagents were shown to be free
of MMTV-like sequences before use. PCR products were
tested for the presence of murine mitochondrial (MoMt)
and genomic DNA to exclude contamination. The
methods used were as described by Deligdisch et al. [27]
and outlined below:
(i) Detection of mouse mitochondrial DNA sequences.
A series of PCR analyses was conducted to detect
MoMt contamination by the detection of cytochrome
oxidase (cox-2) gene as part of the MoMt in any
sample DNA in which MMTV env sequences were
detected. The following primers for cox-2 were used:
mt5982F (5-AGACGCACCTACGGTGAAGA-3) and
mt16267R (5-AGAGTTTTGGTTCACGGAA
CATGA-3). The product yields an amplicon of 286
base pairs. The semi-nested PCR was done using the
primers mt16115F (5-TGCCAAACCCCAAAAA
CACT-3) and mt16267R, which results in a 153-bp
amplicon. After transfer from the gel to a nylon
membrane, the amplicon was detected by
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hybridization with a MoMt 32P-probe (5-GAAC
TAGAATTGATCAGGCAT-3).
(ii)Detection of murine intracisternal A particle long
terminal repeats (IAP)
IAPs are retrotransposon sequences present at the
level of approximately 1000 copies of varying length
per mouse genome. Amplification of the IAP
sequences was carried out in PCR reactions using
the following primers: forward primer (5-ATAA
TCTGCCGCATGAGCCAAGG-3) and reverse
primer (5-AGGAAGAACACCACAGACCAGA-3)
one cycle of 95 °C for 5 min, 35 cycles of 95 °C for
30 s, 58 °C for 30 s, 72 °C for 20 s, and one cycle of
72 °C for 7 min. If present, the products of variable
size, reflecting diversity of the IAP sequences, can be
visualized on a 2% ethidium bromide stained agarose
gel.
Results
The results from each of the two laboratories are shown
in Table 1. Gaps in the results are due to lack of mate-
rials due to exhaustion of the blocks. The time between
the benign breast biopsy specimen and subsequent
breast cancer in the same patients varied from 1 to
11 years.
Outcomes of PCR analyses
MMTV-like env gene sequences were identified in 6
(24%) of 25 benign breast specimens and 9 (36%) of 25
breast cancer specimens. Of the 6 MMTV-like positive
benign specimens, 5 later developed (MMTV-like
positive) cancer.
Eight sets of benign and later breast cancer blocks
were analysed in both the ISMMS and UP laboratories.
Negative outcomes of PCR analyses were the same for 5
sets of blocks. MMTV sequences were identified by both
laboratories in breast cancer of patient 5. MMTV
Table 1 MMTV-like env gene sequences in benign breast tissues
and subsequent breast cancer in the same patients






1 36 Benign neg neg
41 IDC- NST neg neg
2 72 Benign neg
75 DCIS- mucinous neg
3 33 Benign neg neg
44 IDC/DCIS- NST neg neg
4 45 Benign pos neg
46 DCIS-cribriform pos neg
5 50 Benign pos neg
60 ILC-pleomorphic pos pos
6 62 Benign neg
66 DCIS- micropapillary neg
7 47 Benign neg
56 IDC-NST neg
8 49 Benign neg
52 IDC- NST neg
9 46 Benign neg
53 IDC-NST pos
10 48 Hyperplasia pos
52 IDC-NST pos
11 35 Benign neg
46 IDC neg
12 44 Benign neg neg
48 IDC-NST neg neg
13 67 Benign neg
75 IDC-NST neg
14 48 Benign neg neg
54 IDC-NST neg neg
15 42 Benign neg
49 IDC-NST pos
16 42 Benign neg
48 IDC-NST neg
17 39 Benign neg
45 ILC neg
18 53 Benign neg
62 DCIS pos
19 65 Benign pos
67 IDC-NST neg
20 39 Benign neg
44 DCIS-comedo neg
Table 1 MMTV-like env gene sequences in benign breast tissues
and subsequent breast cancer in the same patients (Continued)
21 55 Benign neg
62 IDC-NST neg
22 37 Benign neg neg
39 IDC-cribriform, mucinous neg neg
23 39 Benign pos neg
42 DCIS-comedo pos neg
24 48 Benign pos
54 DCIS-cribriform pos
25 63 Benign neg
67 IDC-NST pos
IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, DCIS ductal
carcinoma in situ, NST no special type, pos positive, neg negative
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sequences were identified by the ISMMS lab only (not the
UP lab) in patients 4 and 23 breast cancer specimens.
Neither MoMt nor IAP DNA sequences were identi-
fied in any of the MMTV-like env positive DNAs. This
indicates there was no murine DNA contamination.
Comparison of MMTV env gene sequences in benign and
breast cancer specimens within the same patient
Over 97% of the MMTV-like env were identical in both
the benign breast biopsy and subsequent breast cancer
in 2 selected patients. These sequences are shown in
Fig. 1. There are variations in approximately 3% of the
sequences between the benign and subsequent breast
cancers that developed several years later in the same
patients. Such variations could be due to alterations in
the MMTV-like genome following integration into the
human genome as has been described for murine retro-
viruses [28] or could also occur during the PCR cycling
procedures. These sequence variations indicate that con-
tamination during PCR analyses was unlikely.
Fig. 1 MMTV env gene sequences identified in benign breast and subsequent breast cancer – sequence sets of two of the same patients,
compared to the MMTV (HMTV) envelope sequence DQ925473. Letters in red signify a change to the reference sequence
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The morphological (histotype) characteristics in 8 of
the 9 MMTV-like sequence positive breast cancers were
similar to MMTV positive mouse (C3H strain mice)
mammary tumours. These characteristics are shown in
Fig. 2.
Discussion
In this study MMTV-like env gene sequences have been
identified in benign breast biopsy specimens prior to the
subsequent development of MMTV-like env positive
breast cancer specimens in the same patient. This is
consistent with prior infection by MMTV-like virus in
breast tissues prior to the development of the same
MMTV-like virus positive breast cancer some years
later. This finding fulfils one key evidentiary criterion
that MMTV-like virus may have a role in some human
breast cancers.
Validity of the data
We consider the data generated in this study to be valid
for the following reasons: (i) The study was conducted
by PCR with primers based on MMTV-like envelope
gene sequences as described by Wang et al. [13]. These
MMTV env gene sequences are unique to the MMTV
genome and are not present in human endogenous
retrovirus sequences (HERV) and which are commonly
identified in studies of the human genome. (ii) Neither
MoMt nor IAP DNA sequences were identified in any
one of the MMTV-like env positive DNAs. This
indicates there was no murine DNA contamination.
(iii) Variations in approximately 2% of the MMTV
env sequences of two specimen pairs were identified.
This is an indication that contamination during PCR
analyses was unlikely. Such variations could be due to
alterations in the MMTV genome following integra-
tion into the human genome. Variations in sequences
can also occur during PCR cycling procedures.
There was one case (case 19 – Table 1) where the earl-
ier biopsy was positive for MMTV-like sequences and
the ensuing breast tumor (developing after two years)
was negative. In addition the results for cases 4 and 23
are not consistent between the two laboratories. There
are several possible reasons: (i) MMTV sequences identi-
fied by PCR can be inconsistent and false negatives are
possible; (ii) MMTV sequences may be present in some,
but not all parts of the tumor; (iii) although unlikely,
changes in MMTV env sequences may have occurred.
The problem of inconsistent outcomes of PCR based
analyses has been considered in detail by Vinner et al.
[29]. There are particular difficulties in obtaining con-
sistent outcomes from PCR analyses of retroviruses
when present in extremely low viral concentrations.
While these problems, including the exhaustion of sev-
eral of the materials, do not invalidate the identification
of MMTV in this current study, it would be wise to rep-
licate this study with increased numbers of patients.
It is of interest that MMTV sequences from the long
terminal repeat (LTR) section of the MMTV genome
have been identified in human breast cancers using Next
Generation massive parallel Sequencing (NGS) [30].
These MMTV sequences were highly homologous to the
reference MMTV genome based on BLAST technology
[31]. These data, based on techniques very different
from PCR, confirm the identification of MMTV-like
gene sequences in human breast tumors and add validity
to PCR based studies that were used in this current in-
vestigation. NGS techniques are not as sensitive for the
identification of retroviral nucleotide sequences as PCR
[29]. This is the reason for the much more frequent
identification of MMTV-like nucleotide sequences by
PCR compared to NGS.
The identification of MMTV-like env gene sequences
in 9 (36%) of 25 Australian breast cancer specimens is a
similar percentage to previous investigations of Austra-
lian breast cancers [7].
It is of considerable interest that the morphology
(histotype) of 8 of 9 MMTV-like positive breast cancers
was similar to the morphology of MMTV positive
Fig. 2 a. MMTV positive human breast cancer. b. MMTV positive mouse mammary tumour
Nartey et al. Infectious Agents and Cancer  (2017) 12:1 Page 5 of 7
mouse mammary tumors. This has been previously ob-
served by Wellings [32] and Lawson et al. [33]. If this
observation is confirmed this has important implications
as it provides potential evidence that MMTV infections
may lead to a specific morphological type of breast
cancer.
Conclusions
The aim of this project has been achieved, namely the
identification of MMTV-like sequences in benign breast
biopsy tissues from women who several years later de-
veloped MMTV-like positive breast cancer. The findings
in this study offer an important contribution to the over-
all body of evidence, which links MMTV-like virus (also
called HMTV) to human breast cancer and fulfills a key
criterion for a possible causal role for the MMTV-like
virus in human breast cancer. Although other viruses
and bacteria have been found in human breast cancer,
none other is known to have a similar parallel in the ani-
mal kingdom. Conclusive proof of HMTV (MMTV-like
virus) as a cause of human breast cancer will open a
new era for prevention and therapy [34].
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